(Q47982958)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12682635%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

The hepatocyte growth factor/Met pathway controls proliferation and apoptosis in multiple myeloma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12682635%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12682635%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Richard J Bende

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12682635%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

6

H M Lokhorst

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12682635%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

7

A C Bloem

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12682635%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

P W B Derksen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12682635%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

D J J de Gorter

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12682635%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

H P Meijer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12682635%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M van Dijk

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12682635%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

S T Pals

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12682635%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 April 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12682635%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12682635%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12682635%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12682635%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

764-774

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12682635%20AND%20SRC:MED&resulttype=core&format=json

Multiple myeloma: evolving genetic events and host interactions

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

Chemokine stromal cell-derived factor-1alpha modulates VLA-4 integrin-mediated multiple myeloma cell adhesion to CS-1/fibronectin and VCAM-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

Vascular endothelial growth factor-induced migration of multiple myeloma cells is associated with beta 1 integrin- and phosphatidylinositol 3-kinase-dependent PKC alpha activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

Insulin-like growth factor induces the survival and proliferation of myeloma cells through an interleukin-6-independent transduction pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

Concomitant expression of hepatocyte growth factor/scatter factor and the receptor c-MET in human myeloma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

The hepatocyte growth factor/Met pathway in development, tumorigenesis, and B-cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

The tyrosine kinase receptor met and its ligand HGF are co-expressed and functionally active in HHV-8 positive primary effusion lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

Fluorescence in situ hybridization analysis shows the frequent occurrence of 14q32.3 rearrangements with involvement of immunoglobulin switch regions in myeloma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

Long-term cultivation of plasma cell leukemia cells and autologous lymphoblasts (LCL) in vitro: A comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

Two distinct human myeloma cell lines originating from one patient with myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

Paracrine regulation of germinal center B cell adhesion through the c-met-hepatocyte growth factor/scatter factor pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

Germinal center B cells rescued from apoptosis by CD40 ligation or attachment to follicular dendritic cells, but not by engagement of surface immunoglobulin or adhesion receptors, become resistant to CD95-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

Minimal Ras-binding domain of Raf1 can be used as an activation-specific probe for Ras.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

Ets transcription factors: nuclear effectors of the Ras-MAP-kinase signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

Biologic sequelae of interleukin-6 induced PI3-K/Akt signaling in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

Activating mutations for the met tyrosine kinase receptor in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

The mutationally activated Met receptor mediates motility and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

Mutant Met-mediated transformation is ligand-dependent and can be inhibited by HGF antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

A novel germ line juxtamembrane Met mutation in human gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

Increasing complexity of Ras signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

Increasing complexity of the Ras signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

A novel recognition motif for phosphatidylinositol 3-kinase binding mediates its association with the hepatocyte growth factor/scatter factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

Regulation of cytokine signaling by B cell antigen receptor and CD40-controlled expression of heparan sulfate proteoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

Differential signaling by alternative HGF isoforms through c-Met: activation of both MAP kinase and PI 3-kinase pathways is insufficient for mitogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

The multisubstrate adapter Gab1 regulates hepatocyte growth factor (scatter factor)-c-Met signaling for cell survival and DNA repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

Dual Role of Phosphatidylinositol-3,4,5-trisphosphate in the Activation of Protein Kinase B

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

Role of the AKT kinase in expansion of multiple myeloma clones: effects on cytokine-dependent proliferative and survival responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

Direct control of the Forkhead transcription factor AFX by protein kinase B

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

Signal pathways involved in activation of p70S6K and phosphorylation of 4E-BP1 following exposure of multiple myeloma tumor cells to interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

BH3 domain of BAD is required for heterodimerization with BCL-XL and pro-apoptotic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

7 January 2021

Role of hepatocyte growth factor and its receptor c-met in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

7 January 2021

Phosphatidylinositol 3-kinase activity is required for hepatocyte growth factor-induced mitogenic signals in epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

7 January 2021

Hepatocyte growth factor-induced proliferation of primary hepatocytes is mediated by activation of phosphatidylinositol 3-kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

7 January 2021

The cytokine hepatocyte growth factor/scatter factor inhibits apoptosis and enhances DNA repair by a common mechanism involving signaling through phosphatidyl inositol 3' kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

7 January 2021

AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402875

7 January 2021